James McCormack

3.7k total citations
102 papers, 2.1k citations indexed

About

James McCormack is a scholar working on Economics and Econometrics, Pharmacology and Surgery. According to data from OpenAlex, James McCormack has authored 102 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Economics and Econometrics, 18 papers in Pharmacology and 17 papers in Surgery. Recurrent topics in James McCormack's work include Health Systems, Economic Evaluations, Quality of Life (23 papers), Meta-analysis and systematic reviews (11 papers) and Lipoproteins and Cardiovascular Health (10 papers). James McCormack is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (23 papers), Meta-analysis and systematic reviews (11 papers) and Lipoproteins and Cardiovascular Health (10 papers). James McCormack collaborates with scholars based in Canada, United States and United Kingdom. James McCormack's co-authors include G. Michael Allan, Peter J. Jewesson, Michael R. Kolber, Christina Korownyk, Scott Garrison, Alan Cassels, Peter Loewen, Ben Vandermeer, Carolyne J. Montgomery and Adrienne J. Lindblad and has published in prestigious journals such as The Lancet, Circulation and PLoS ONE.

In The Last Decade

James McCormack

90 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James McCormack Canada 27 367 313 265 251 250 102 2.1k
Jeff J. Guo United States 29 230 0.6× 309 1.0× 368 1.4× 197 0.8× 291 1.2× 121 2.9k
Mette Madsen Denmark 31 476 1.3× 254 0.8× 318 1.2× 499 2.0× 310 1.2× 73 3.9k
Martin Schulz Germany 31 315 0.9× 289 0.9× 262 1.0× 492 2.0× 538 2.2× 155 4.1k
Patrick Blin France 30 408 1.1× 164 0.5× 249 0.9× 392 1.6× 186 0.7× 152 3.4k
Robert J. Valuck United States 35 406 1.1× 335 1.1× 426 1.6× 406 1.6× 556 2.2× 106 3.8k
Francesca Cunningham United States 28 283 0.8× 273 0.9× 289 1.1× 372 1.5× 247 1.0× 109 2.9k
Zachary A. Marcum United States 32 376 1.0× 423 1.4× 354 1.3× 263 1.0× 349 1.4× 150 3.8k
Christina Korownyk Canada 20 340 0.9× 297 0.9× 360 1.4× 196 0.8× 111 0.4× 103 1.9k
Kenneth A. Lawson United States 28 178 0.5× 343 1.1× 418 1.6× 154 0.6× 231 0.9× 119 2.9k
Elizabeth D. Kantor United States 23 202 0.6× 197 0.6× 598 2.3× 310 1.2× 158 0.6× 55 2.8k

Countries citing papers authored by James McCormack

Since Specialization
Citations

This map shows the geographic impact of James McCormack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James McCormack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James McCormack more than expected).

Fields of papers citing papers by James McCormack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James McCormack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James McCormack. The network helps show where James McCormack may publish in the future.

Co-authorship network of co-authors of James McCormack

This figure shows the co-authorship network connecting the top 25 collaborators of James McCormack. A scholar is included among the top collaborators of James McCormack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James McCormack. James McCormack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turgeon, Ricky D., et al.. (2024). Metformin for Type 2 diabetes mellitus. Academic Emergency Medicine. 31(8). 832–834.
2.
McCormack, James, et al.. (2024). SGLT‐2 inhibitors and GLP‐1 receptor agonists for Type 2 diabetes. Academic Emergency Medicine. 31(4). 408–411. 1 indexed citations
3.
Haverkate, Manon, Jennifer Reid, Salimah Z. Shariff, et al.. (2023). Quality of antibiotic prescribing for pediatric community-acquired Pneumonia in outpatient care. BMC Pediatrics. 23(1). 542–542. 2 indexed citations
4.
Korownyk, Christina, et al.. (2020). Successes, lessons and opportunities: 15-year follow-up of an integrated evidence-based medicine curriculum. BMJ evidence-based medicine. 26(5). 241–245. 1 indexed citations
5.
Blom, Jeanet W., Christiane Muth, Paul Glasziou, et al.. (2020). Describing deprescribing trials better: an elaboration of the CONSORT statement. Journal of Clinical Epidemiology. 127. 87–95. 11 indexed citations
6.
McCormack, James & Daniel T. Holmes. (2020). Your results may vary: the imprecision of medical measurements. BMJ. 368. m149–m149. 27 indexed citations
7.
McCormack, James. (2018). Combination Drug Therapy for Hypertension. The Canadian Journal of Hospital Pharmacy. 51(5).
8.
McCormack, James, et al.. (2018). Regularly Scheduled Oral Morphine for Post Surgical Orthopedic Pain. The Canadian Journal of Hospital Pharmacy. 45(3).
9.
McCracken, Rita, James McCormack, Margaret J. McGregor, Sabrina T. Wong, & Scott Garrison. (2017). Associations between polypharmacy and treatment intensity for hypertension and diabetes: a cross-sectional study of nursing home patients in British Columbia, Canada. BMJ Open. 7(8). e017430–e017430. 27 indexed citations
10.
Loewen, Peter, et al.. (2016). Design and implementation of an integrated medication management curriculum in an entry-to-practice doctor of pharmacy program. Pharmacy Education. 16. 4 indexed citations
11.
Lehman, Richard, et al.. (2015). Ten Commandments for patient-centred treatment. British Journal of General Practice. 65(639). 532–533. 6 indexed citations
12.
Allan, G. Michael, Scott Garrison, & James McCormack. (2014). Comparison of cardiovascular disease risk calculators. Current Opinion in Lipidology. 25(4). 254–265. 33 indexed citations
13.
Arroll, Bruce, G. Michael Allan, C. Raina Elley, et al.. (2012). Viewpoint: Diagnosis in primary care: probabilistic reasoning. Journal of Primary Health Care. 4(2). 166–173. 7 indexed citations
14.
McCormack, James, et al.. (2008). Estimating Renal Function for Drug Dosing: Rewriting the Gospel?. The Canadian Journal of Hospital Pharmacy. 61(2). 4 indexed citations
15.
McCormack, James, Lisa Dolovich, Mitchell Levine, et al.. (2003). Providing evidence‐based information to patients in general practice and pharmacies: what is the acceptability, usefulness and impact on drug use?. Health Expectations. 6(4). 281–289. 16 indexed citations
16.
Mynett‐Johnson, Lesley, et al.. (1998). Evidence for an allelic association between bipolar disorder and a Na+, K+ adenosine triphosphatase alpha subunit gene (ATP1A3). Biological Psychiatry. 44(1). 47–51. 64 indexed citations
17.
McCormack, James. (1996). Drug therapy decision making guide. Saunders eBooks. 3 indexed citations
18.
McCormack, James, et al.. (1990). X toolkit : the intrinsics & Athena Widgets. 1 indexed citations
19.
McCormack, James, et al.. (1990). X Tool Kit: Intrinsics and Athena Widgets. 1 indexed citations
20.
McCormack, James & Jerome J. Schentag. (1987). Potential Impact of Quantitative Susceptibility Tests on the Design of Aminoglycoside Dosing Regimens. Drug Intelligence & Clinical Pharmacy. 21(2). 187–191. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026